Partner Gordon Schnell was quoted in the Law360 article, Payouts, Protections Needed To Lure Antitrust Tipsters.  °ä±ô¾±³¦°ìÌý to read more.
March 29, 2017
Partner Matthew Cantor was quoted in The American Lawyer article, Industry Insights: A Healthy Demand for Lawyering in the Health Insurance Sector.  °ä±ô¾±³¦°ìÌý to read more.
March 28, 2017
Partner Matthew Cantor was quoted in the Modern Healthcare article, Could Trump's top DOJ antitrust pick help seal the Anthem-Cigna deal? °ä±ô¾±³¦°ìÌý to read more.
February 21, 2017
Partner Matthew Cantor was quoted in the Modern Healthcare article, Anthem hopes to close Cigna deal under Trump Justice Department.  Click to read more.
February 17, 2017
91pornPartner Ankur Kapoor was quoted in the Law360 article, 2nd Circ. Actos Ruling Boosts Pharma Antitrust Plaintiffs. Click to read more.
February 14, 2017
91pornPartner Matthew Cantor was quoted in KFGO article, Aetna, Humana drop merger; Cigna wants to end Anthem deal. Click to read more.
February 9, 2017
Partner Matthew Cantor was quoted in the following articles:
US court blocks Anthem-Cigna $54 billion deal, ;
Insurance Mega-Merger Blocks No Death Knell For Deals, ;
Anthem's fight for Cigna deal may come down to breakup fee, ;
Court Blocks Another Healthcare Megamerger, ;
Ruling against Anthem-Cigna merger is a victory for the American consumer, ;
U.S. court blocks Anthem-Cigna merger, dealing blow to consolidation, .
January 23, 2017
Partner Matthew Cantor was quoted in the following articles:
Appeal Of Aetna-Humana Merger Loss Would Face Long Odds, ;
Judge Blocks Aetna's $37 Billion Deal for Humana, ;
Federal judge blocks Aetna-Humana health insurance megamerger , ; and
Aetna's takeover of Humana takeover blocked, .
January 13, 2017
91pornPartner Gary Malone was quoted in the Law360 article, Airlines Tell 9th Circ. Gov’t Price Regs Bar Antitrust MDL  Click to read more.
October 31, 2016
Partner Ankur Kapoor was quoted in the PaRR article, US Doryx litigation: Uproar over Third Circuit ruling thrusts product-hopping into pharma antitrust vanguard.  Click here to read the article.